Correction: Rhodacyanine Derivative Selectively Targets Cancer Cells and Overcomes Tamoxifen Resistance.

Correction: Rhodacyanine Derivative Selectively Targets Cancer Cells and Overcomes Tamoxifen Resistance.

Bibliographic Details
Main Authors:	John Koren, Yoshinari Miyata, Janine Kiray, John C. O'Leary, Lana Nguyen, Jianping Guo, Laura J. Blair, Xiaokai Li, Umesh K. Jinwal, Jin Q. Cheng, Jason E. Gestwicki, Chad A. Dickey
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2012-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3398052

Similar Items

Rhodacyanine derivative selectively targets cancer cells and overcomes tamoxifen resistance.
by: John Koren, et al.
Published: (2012-01-01)

Correction: Rhodacyanine Derivative Selectively Targets Cancer Cells and Overcomes Tamoxifen Resistance
Published: (2012-01-01)

Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden
by: Abisambra Jose F, et al.
Published: (2010-11-01)

A new anti-depressive strategy for the elderly: ablation of FKBP5/FKBP51.
by: John C O'Leary, et al.
Published: (2011-01-01)

Identification of potential target genes of honokiol in overcoming breast cancer resistance to tamoxifen
by: Hermawan, Adam, et al.
Published: (2022)

Identification of potential target genes of honokiol in overcoming breast cancer resistance to tamoxifen
by: Adam Hermawan, et al.
Published: (2022-12-01)

Inhibition of β-Catenin to Overcome Endocrine Resistance in Tamoxifen-Resistant Breast Cancer Cell Line.
by: Hye Sung Won, et al.
Published: (2016-01-01)

Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine
by: Yuntao Wang MS, et al.
Published: (2021-03-01)

Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer
by: Cen Jiang, et al.
Published: (2023-10-01)

Age-associated epigenetic upregulation of the FKBP5 gene selectively impairs stress resiliency.
by: Jonathan J Sabbagh, et al.
Published: (2014-01-01)

Tamoxifen inhibits the biosynthesis of inositolphosphorylceramide in Leishmania
by: Cristiana T. Trinconi, et al.
Published: (2018-12-01)

The benefits and costs of tamoxifen for breast cancer prevention
by: Simon D. Eckermann, et al.
Published: (2003-02-01)

The gut microbiota during tamoxifen therapy in patients with breast cancer
by: Lars E. Hillege, et al.
Published: (2025-03-01)

Tamoxifen for Breast Cancer
by: A Karn, et al.
Published: (2010-03-01)

Use of antipsychotics with tamoxifen
by: H. Ghabi, et al.
Published: (2021-04-01)

Tamoxifen and the singing voice.
by: Andrew Herxheimer
Published: (2005-09-01)

Tamoxifen- Induced Dermatomyositis
by: Bandyopadhyay Debabrata, et al.
Published: (1997-01-01)

Tamoxifen and ovarian function.
by: Martine Berliere, et al.
Published: (2013-01-01)

Ocular toxicity of tamoxifen
by: Sekhar G, et al.
Published: (1995-01-01)

top universities guide ... /
by: John, O'Leary
Published: (2010)

Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer
by: Ozge Saatci, et al.
Published: (2024-06-01)

Targeting Pin1 by All-Trans Retinoic Acid (ATRA) Overcomes Tamoxifen Resistance in Breast Cancer via Multifactorial Mechanisms
by: Songyin Huang, et al.
Published: (2019-12-01)

Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
by: Seo Yun Moon, et al.
Published: (2021-08-01)

Data from SILAC-based quantitative analysis of lysates from mouse microglial cells treated with Withaferin A (WA)
by: Malathi Narayan, et al.
Published: (2016-06-01)

2070 High-intensity focused ultrasound (HIFU) can be used synergistically with tamoxifen to overcome resistance in preclinical and patient derived xenograft models
by: Rachel Sabol, et al.
Published: (2018-06-01)

Five years of tamoxifen--or more?
by: Peto, R
Published: (1996)

Tamoxifen in breast conservation therapy.
by: Lee, K, et al.
Published: (1995)

Variation in use of adjuvant tamoxifen.
by: Davies, C, et al.
Published: (1998)

Correction: Tamoxifen and Ovarian Function.
by: Martine Berliere, et al.
Published: (2013-01-01)

Correction: Tamoxifen and Ovarian Function
Published: (2013-01-01)

Adeno-associated virus-mediated rescue of the cognitive defects in a mouse model for Angelman syndrome.
by: Jennifer L Daily, et al.
Published: (2011-01-01)

Small molecule inhibitor targeting the Hsp70-Bim protein–protein interaction in estrogen receptor-positive breast cancer overcomes tamoxifen resistance
by: Ting Song, et al.
Published: (2024-02-01)

Cancer Cells Show Higher Sensitivity to Melatonin-Tamoxifen Drug Conjugates than to Combination of Melatonin and Tamoxifen
by: Mohamed Akmal Marzouk, et al.
Published: (2024-11-01)

The response of anti-VEGF therapy and tamoxifen withdrawal of tamoxifen-induced cystoid macular edema in the same patient
by: Chuanyu Li, et al.
Published: (2021-05-01)

Human genetic determinants of tamoxifen metabolism
by: Koh, Everett Chier Wei
Published: (2021)

WITHDRAWN: Tamoxifen for early breast cancer.
by: Clarke, M
Published: (2008)

Autoimmune progesterone dermatitis responding to Tamoxifen.
by: Stephens, C, et al.
Published: (1989)

Electrochemical biosensor for simultaneously detection of Tamoxifen
by: Hasret Subak
Published: (2022-12-01)

Compared Antileishmanial Activity of Clomiphene and Tamoxifen
by: Sergio Sifontes-Rodríguez, et al.
Published: (2024-10-01)

Endometrial thickness in tamoxifen-treated women
by: Yiu-Tai Li, et al.
Published: (2023-11-01)